BVS

BVS

Bioventus Inc

Bioventus Inc. develops medical devices focused on musculoskeletal therapies, offering products such as hyaluronic acid injections, peripheral nerve stimulation devices, ultrasonic surgical systems, and bone graft substitutes for pain relief and recovery.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$918today

Score Overview

1 Year
Score
Net Growth139.59%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth2.42%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score7.1
Net Growth181.10%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth35.03%
Rev Trend80%
Revenue Consistencyโ€”
All Time
Score
Net Growth181.10%
Net Trend80%
Net Income Consistency
Rev Growth35.03%
Rev Trend80%
Revenue Consistency

See the full market ranking โ†’

Bioventus Inc fundamental performance

Between 2021 and 2025, revenue grew from $ 430M to $ 568M and net income grew from $ 19M to $ 22M. Revenue increased in 80% of the years measured; net income in 80%.

Bioventus Inc currently holds a 5-year HDB Score of 7.1 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 13.91โ€”
1 Year2025-08-12
$ 7.3190.36%
5 Years2021-08-12
$ 15.16-8.21%
All Time2021-02-11
$ 19.21-27.56%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 581M$ 54M$ 29M
2025$ 568M$ 22M$ 51M
2024$ 573M-$ 33M$ 41M
2023$ 512M-$ 156M$ 36M
2022$ 512M-$ 158M$ 30M
IPO2021$ 430M$ 19M$ 43M

Explore beyond BVS

You're looking at Bioventus Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies